Beyond Geographies and Business Areas
We Build Partnerships That Transcend Boundaries
Driven by our passion for science, access, and ease – we partner to ensure progress for all.
Why Partner with Us
Robust global networks
A truly global company, connecting over 30 countries
Multiple areas of opportunity
From co-developing drugs to out-licensing – collaboration is key
Legacy of results and delivery
Over 25 years of forwarding science at Dr. Reddy’s Biologics
Our Network of Partners
- All
- In-licensing
- Out-licensing
- Co-development
Alvotech
Healthcare Pharmaceuticals Limited
Coya Therapeutics
Processes Involved Toward Partnership
Please expect to go through the following processes on the way to successful deal closure.
Write to us using the Enquiry Form below.
Non-Disclosure Agreement (NDA):
Business Case and Opportunity Assessment:
Term Sheet:
Due Diligence:
Licensing Agreement:
Supporting Agreements:
Our Network
- Publication
- 18-06-2015
Abstract 398 Efficacy and safety of rituximab biosimilar in b-cell Lymphoma patients treated with chemo immunotherapy: Single-centre retrospective analysis
- Publication
- 25-06-2018
A comparative pharmacokinetic study of DRL_BZ, a candidate biosimilar of bevacizumab, with Avastin (EU and US) in healthy male subjects
- Publication
- 12-10-2023
Comparison of Efficacy and Safety of a Bevacizumab Biosimilar, in Combination with Chemotherapies, in Nonresectable Metastatic Colorectal Cancer and in Advanced Nonsquamous Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study
- Publication
- 31-08-2021
A randomized, double-blind, parallel-group, single-dose comparative pharmacokinetic study of DRL_TZ, a candidate biosimilar of trastuzumab, with Herceptin (EU) in healthy adult males
Yashwanth
Engineering
Korra Siddu
Quality
Dolai Vicky
Manufacturing
Siva Venkata
Packaging
Namrata Gowda
Manufacturing
Bricks of Biologics, appreciates the contribution and celebrates our people who are the building blocks of Dr. Reddy's Biologics.
Bricks of biologics in general refers to bio-bricks as genetic building blocks which are DNA sequences that can be assembled to create complex biological systems.